Canadian Agency for Drugs and Technologies in Health (CADTH) is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.
Home-Based Dialysis for the Treatment of End-Stage Kidney Disease: What Does the Evidence Say?
When it comes to dialysis treatment, several options are available for patients with end-stage kidney disease (ESKD). However, in Canada, traditional hemodialysis offered in a clinical setting remains the most frequently used method. Join CADTH and Continuing Education and Development
for Nurses (CEDN) for a webinar on the current evidence on home dialysis and how this is relevant to the Saskatchewan kidney care context.
This presentation will be of interest to nurses, physicians, allied health professionals, researchers, educators, administrators, and Health Sciences students.
• Clinical effectiveness and cost considerations of homebased dialysis treatments as they compare to traditional in-centre hemodialysis
• Patient (and caregiver) experiences and perspectives on dialysis treatment
• Common implementation issues for home-based dialysis
• Dialysis considerations for special groups of patients (for example, patients in rural or remote areas)